Section Arrow
INVA.NASDAQ
- Innoviva
Quotes are at least 15-min delayed:2026/09/01 18:31 EDT
After Hours
Last
 21.08
0 (0.00%)
Bid
20.55
Ask
22.5
High 21.08 
Low 21.08 
Volume 61.46K 
Regular Hours (Closed)
Last
 21.08
+0.31 (+1.49%)
Day High 
21.175 
Prev. Close
20.77 
1-M High
22.09 
Volume 
798.74K 
Bid
20.55
Ask
22.5
Day Low
20.94 
Open
20.97 
1-M Low
20.2 
Market Cap 
1.50B 
Currency 美元 
P/E 4.82 
%Yield 1.19 
10-SMA 21.09 
20-SMA 20.95 
50-SMA 21.63 
52-W High 25.145 
52-W Low 16.52 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
4.31/2.37
Enterprise Value
1.77B
Balance Sheet
Book Value Per Share
17.07
Cash Flow
Cash Flow Yield
0.11
Income Statement
Total Revenue
411.33M
Operating Revenue Per Share
4.02
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
AIMAIM ImmunoTech Inc.0.236+0.01+4.42%-- 
After Hours 0.2358 -0.0002 -0.08%
ALMSAlumis Inc.9.47-12.34-56.58%-- 
After Hours 9.43 -0.04 -0.42%
MRNAModerna154.27+13.93+9.93%-- 
After Hours 152 -2.27 -1.47%
HUMAHumacyte0.5704-0.031-5.15%-- 
After Hours 0.5766 +0.0062 +1.09%
IVVDInvivyd0.8799-0.075-7.85%-- 
After Hours 0.86 -0.0199 -2.26%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its productoffering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.